← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $166B	1,970	+90	+5%	$146B
2	2 Amgen AMGN $230B	1,455	+73	+5%	$98.6B
3	3 Eli Lilly LLY $1.08T	1,221	+73	+6%	$71.2B
4	4 McKesson MCK $114B	974	+48	+5%	$38.5B
5	5 Becton Dickinson BDX $51.5B	966	+35	+4%	$27.6B
6	6 Teva Pharmaceutical Industries Limited TEVA $47.5B	877	+53	+6%	$40B
7	7 Conagra Brands CAG $6.61B	656	+18	+3%	$14B
8	8 Regeneron Pharmaceuticals REGN $80.1B	577	+14	+2%	$39.7B
9	9 Novo Nordisk NVO $168B	549	+23	+4%	$11.8B
10	10 DaVita DVA $11.5B	503	+32	+7%	$12.3B
11	11 AstraZeneca AZN $251B	390	+19	+5%	$7.54B
12	12 ResMed RMD $33.1B	352	+38	+12%	$4.45B
13	13 Opko Health OPK $1.02B	273	+5	+2%	$1.16B
14	14 Accendra Health ACH $24.1M	270	+19	+8%	$2.26B
15	15 West Pharmaceutical WST $26.4B	249	+1	+0.4%	$4.06B
16	16 Herbalife HLF $1.49B	213	+2	+0.9%	$5.25B
17	17 DELISTED CATALENT, INC. CTLT	188	+12	+7%	$3.11B
18	18 Dr. Reddy's Laboratories RDY $10.6B	174	-32	-16%	$1.34B
19	19 MannKind Corp MNKD $971M	173	-12	-6%	$167M
20	20 Tootsie Roll Industries TR $2.87B	171	+4	+2%	$426M
21	21 Alaunos Therapeutics TCRT $5.26M	156	+18	+13%	$512M
22	22 Fresenius Medical Care FMS $11.5B	148	+7	+5%	$426M
23	23 DELISTED WW International WW	144	+29	+25%	$1.37B
24	24 Medifast MED $132M	131	+6	+5%	$297M
25	ARNA 25 DELISTED Arena Pharmaceuticals Inc ARNA	121	+1	+0.8%	$245M